Page last updated: 2024-10-22

albendazole and Carcinoma, Anaplastic

albendazole has been researched along with Carcinoma, Anaplastic in 1 studies

Research Excerpts

ExcerptRelevanceReference
" dosing (ABZ, 150 mg/kg) led to the highest degree of tumor growth suppression (P<0."5.33Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. ( Akhter, J; Lu, Y; Morris, DL; Pourgholami, MH; Wang, L, 2005)
" dosing (ABZ, 150 mg/kg) led to the highest degree of tumor growth suppression (P<0."1.33Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. ( Akhter, J; Lu, Y; Morris, DL; Pourgholami, MH; Wang, L, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pourgholami, MH1
Akhter, J1
Wang, L1
Lu, Y1
Morris, DL1

Other Studies

1 other study available for albendazole and Carcinoma, Anaplastic

ArticleYear
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:5

    Topics: Albendazole; Animals; Anthelmintics; Apoptosis; Carcinoma; Colorectal Neoplasms; Humans; In Situ Nic

2005